Showing results (171-180 of 212) with videos related to
Sort By:
Pageof 22
Neurology|May 11, 2016
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED]: Report of the Guideline Development Subcommittee of the American Academy of NeurologyDavid M Simpson, Mark Hallett, Eric J Ashman, et al.American Journal of Epidemiology|June 27, 2014
The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIVEdward R Hammond, Rosa M Crum, Glenn J Treisman, et al.The Journal of Antimicrobial Chemotherapy|November 25, 2010
Efavirenz concentrations in CSF exceed IC50 for wild-type HIVBrookie M Best, Peter P Koopmans, Scott L Letendre, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2013
Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorderRonald J Ellis, Scott Letendre, Florin Vaida, et al.Journal of Neurovirology|June 13, 2015
CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV diseaseAlbert M Anderson, Christine Fennema-Notestine, Anya Umlauf, et al.The Journal of Antimicrobial Chemotherapy|November 13, 2012
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentrationDavid Croteau, Steven S Rossi, Brookie M Best, et al.The Lancet. HIV|June 19, 2019
Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort studyAlessandro Livelli, Florin Vaida, Ronald J Ellis, et al.Antimicrobial Agents and Chemotherapy|February 1, 2012
Therapeutic amprenavir concentrations in cerebrospinal fluidDavid Croteau, Scott Letendre, Brookie M Best, et al.Neuroimage|November 6, 2004
Regional patterns of brain metabolites in AIDS dementia complexConstantin T Yiannoutsos, Thomas Ernst, Linda Chang, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 5, 2011
Neurocognitive impact of substance use in HIV infectionDesiree A Byrd, Robert P Fellows, Susan Morgello, et al.Pageof 22